Myles David C. (CIK 0001831216)

Latest company ownership

OLMA - Olema Pharmaceuticals, Inc.

Role: CH. DISCOV. & NON-CLIN DEV OFF

Shares held

195,000

Last filed at

Feb 5, 2024

Confidence Score

25.7

2025Q4

Confidence Score History

2021Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 19, 2025	Dec 23, 2025	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	17.5	-60,000	-7.79%	✗	$1.6M
Dec 9, 2024	Dec 11, 2024	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	87.5	+22,684	3.05%	✗	$234.9K
Nov 20, 2023	Nov 22, 2023	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	82.5	+12,621	1.73%	✗	$196.2K
Nov 8, 2023	Nov 13, 2023	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	58.8	-200	-0.03%	✓	$3.5K
Nov 1, 2023	Nov 3, 2023	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	45.0	-10,541	-1.43%	✓	$160.8K
Sep 19, 2023	Sep 21, 2023	Olema Pharmaceuticals, Inc.	CH. DISCOV. & NON-CLIN DEV OFF	Sell	38.8	-20,000	-2.63%	✓	$253.4K
Dec 10, 2021	Dec 14, 2021	Olema Pharmaceuticals, Inc.	CHIEF DEVELOPMENT OFFICER	Sell	22.5	-10,000	-1.31%	✗	$103K